Astrana Health Inc.Astrana Health Inc.Astrana Health Inc.

Astrana Health Inc.

No trades
No trades

Compare with Astrana Health Inc.


Market capitalization
‪1.97 B‬USD
0.83USD
‪22.49 M‬USD
‪3.18 B‬USD
‪39.23 M‬
Beta (1Y)
1.08
Last report date
Aug 6, 2026
Report period
Q2 2026
EPS
0.40USD
Revenue
‪972.50 M‬USD
Earnings call summary

Q2 2026 saw 49% revenue growth and 43% adjusted EBITDA growth, with strong free cash flow and deleveraging ahead of schedule. Full-year guidance was raised, driven by organic growth, successful integration of Prospect Health, and expanding full risk contracts. Medicaid attrition remains a focus, but Medicare performance is strong.

Employees (FY)
‪3 K‬
Change (1Y)
‪+1.1 K‬+57.89%
Revenue / Employee (1Y)
‪1.06 M‬USD
Net income / Employee (1Y)
‪7.50 K‬USD

Company info


CEO
Brandon K. Sim
Headquarters
Alhambra
Founded
1985
IPO date
Apr 9, 1999
ISIN
US03763A2078
CUSIP
03763A207
FIGI
BBG000H7ZK57
Identifiers
ISIN US03763A2078
CFI code
ESVUFR
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.09%
Market value‪102.51 M‬
Weight0.06%
Market value‪46.71 M‬
Weight0.05%
Market value‪21.05 M‬
Weight0.11%
Market value‪16.48 M‬
Weight0.09%
Market value‪15.81 M‬
Weight0.18%
Market value‪15.01 M‬
Weight0.05%
Market value‪9.10 M‬
Weight0.18%
Market value‪9.04 M‬
Weight0.03%
Market value‪8.08 M‬
Weight0.08%
Market value‪7.56 M‬
Weight0.05%
Market value‪7.28 M‬

Explore more ETFs 

Frequently asked questions


The current price of ASTH is 39.16 USD — it has decreased by −1.48% in the past 24 hours. Watch Astrana Health Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Astrana Health Inc. stocks are traded under the ticker ASTH.
ASTH stock has risen by 3.32% compared to the previous week, the month change is a −11.86% fall, over the last year Astrana Health Inc. has showed a 32.75% increase.
We've gathered analysts' opinions on Astrana Health Inc. future price: according to them, ASTH price has a max estimate of 65.00 USD and a min estimate of 41.00 USD. Watch ASTH chart and read a more detailed Astrana Health Inc. stock forecast: see what analysts think of Astrana Health Inc. and suggest that you do with its stocks.
ASTH reached its all-time high on Nov 15, 2021 with the price of 133.23 USD, and its all-time low was 0.001 USD and was reached on Nov 26, 2007. View more price dynamics on ASTH chart.
See other stocks reaching their highest and lowest prices.
ASTH stock is 4.61% volatile and has beta coefficient of 1.08. Track Astrana Health Inc. stock price on the chart and check out the list of the most volatile stocks — is Astrana Health Inc. there?
Today Astrana Health Inc. has the market capitalization of ‪1.97 B‬, it has decreased by −9.47% over the last week.
Yes, you can track Astrana Health Inc. financials in yearly and quarterly reports right on TradingView.
Astrana Health Inc. is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
ASTH earnings for the last quarter are 0.40 USD per share, whereas the estimation was 0.34 USD resulting in a 19.13% surprise. The estimated earnings for the next quarter are 0.44 USD per share. See more details about Astrana Health Inc. earnings.
Astrana Health Inc. revenue for the last quarter amounts to ‪972.50 M‬ USD, despite the estimated figure of ‪982.23 M‬ USD. In the next quarter, revenue is expected to reach ‪1.02 B‬ USD.
ASTH net income for the last quarter is ‪19.74 M‬ USD, while the quarter before that showed ‪14.44 M‬ USD of net income which accounts for 0.00% change. Track more Astrana Health Inc. financial stats to get the full picture.
No, ASTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 19, 2026, the company has ‪3 K‬ employees. See our rating of the largest employees — is Astrana Health Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Astrana Health Inc. EBITDA is ‪163.48 M‬ USD, and current EBITDA margin is 3.91%. See more stats in Astrana Health Inc. financial statements.
Like other stocks, ASTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Astrana Health Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Astrana Health Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Astrana Health Inc. stock shows the buy signal. See more of Astrana Health Inc. technicals for a more comprehensive analysis.